Abstract Details
Activity Number:
|
350
|
Type:
|
Contributed
|
Date/Time:
|
Tuesday, August 5, 2014 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #313335
|
|
Title:
|
Accounting for Pre-Treatment Dropout Using Inverse Probability Weighting: Application to a Phase III Clinical Trial in Multiple Sclerosis
|
Author(s):
|
Stephen Lake*+ and Amy Cinar and Jeff Palmer and David Margolin and Michael Panzara
|
Companies:
|
Genzyme and Genzyme and Genzyme and Genzyme and Genzyme
|
Keywords:
|
dropout ;
inverse probability weighting ;
multiple sclerosis ;
missing data ;
proportional hazards
|
Abstract:
|
In open label studies, patients may opt to discontinue prior to treatment after learning to which treatment they were randomized to receive. This patient selection process has implications for statistical inference if the patients who withdraw prior to treatment are different than the patients who are treated and/or if the withdrawal is imbalanced between treatment groups. The use of inverse probability weighting to account for dropout in this setting was explored. Simulations results demonstrate that this is an effective means for addressing this type of dropout. This approach was applied to an open label, rater-blinded, phase 3 clinical trial in multiple sclerosis. The results of a sensitivity analysis using inverse probability weighting demonstrate that the primary efficacy results from the study are robust to pre-treatment dropout.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2014 program
|
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.